Vabysmo 6 MG/0.05 ML syringe 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCRV7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,762
Award facts
- Contract value 100% obligated
- $11,762.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,762.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on January 21, 2026, with an ultimate completion date of February 11, 2026, carries no set-aside designation, indicating the award was made through open competition. The contract leverages DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion enterprise-wide acquisition strategy designed to provide comprehensive pharmaceutical and medical supply solutions to military healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded in November 2025 with a ceiling value of $499,999,999 and completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors responsible for supplying branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring DoD medical requirements globally.
Quick answers
Who was awarded contract SPE2DR26FCRV7?
SPE2DR26FCRV7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FCRV7 worth?
The government has obligated $11,762 on SPE2DR26FCRV7.
Is contract SPE2DR26FCRV7 an order under another contract?
Yes. SPE2DR26FCRV7 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRV7 competed?
The extent of competition for SPE2DR26FCRV7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award